Baricitinib can effectively treat polymyalgia rheumatica (PMR) without the use of oral glucocorticoids, according to results from a small, randomized, double-blind, placebo-controlled study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback